Medicare Enrolled

Dr. Behnam Khaleghi, MD

Rheumatology · Orange, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
805 W LA VETA AVE, Orange, CA 92868
7146289342
In practice since 2005 (20 years)
NPI: 1154306678 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khaleghi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khaleghi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khaleghi

Dr. Behnam Khaleghi is a rheumatology specialist in Orange, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Khaleghi performed 1,153 Medicare services across 615 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khaleghi received a total of $30,464 from 47 pharmaceutical and/or device companies across 1468 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khaleghi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 46% volume in CA $30,464 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,153
Medicare services
Top 46% in CA for rheumatology
615
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~58 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
435 $142 $365
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
131 $74 $235
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
118 $87 $350
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
89 $103 $295
New patient office visit, complex (60-74 min) 84 $171 $465
Limited ultrasound of joint or extremity
A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels.
82 $36 $175
Viscosupplementation injection for joint
An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning.
81 $58 $345
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
47 $12 $30
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
39 $135 $400
Injection, methylprednisolone acetate, 40 mg 31 $6 $52
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
16 $121 $295
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
31.1% medium
67.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$30,464
Total received (2018-2024)
Avg $4,352/year across 7 years
Top 14% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
1,468
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,451 (100.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,861
2023
$4,581
2022
$4,782
2021
$4,801
2020
$3,609
2019
$4,016
2018
$3,815

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$766
Amgen Inc.
$587
GlaxoSmithKline, LLC.
$480
Lilly USA, LLC
$460
Novartis Pharmaceuticals Corporation
$399
PFIZER INC.
$387
Janssen Biotech, Inc.
$293
AstraZeneca Pharmaceuticals LP
$256
ANI Pharmaceuticals, Inc.
$220
UCB, Inc.
$206
Fresenius Kabi USA, LLC
$189
Boehringer Ingelheim Pharmaceuticals, Inc.
$184
Radius Health, Inc.
$136
Aurinia Pharma U.S., Inc.
$122
Alexion Pharmaceuticals, Inc.
$74
Mallinckrodt Hospital Products Inc.
$46
Organon Llc
$33
GENZYME CORPORATION
$23
Top 3 companies account for 37.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$4,433
Lilly USA, LLC
$3,467
Novartis Pharmaceuticals Corporation
$2,364
ABBVIE INC.
$2,179
PFIZER INC.
$2,076
Janssen Biotech, Inc.
$1,890
GlaxoSmithKline, LLC.
$1,826
AbbVie Inc.
$1,697
Horizon Therapeutics plc
$1,313
AbbVie, Inc.
$1,084
AstraZeneca Pharmaceuticals LP
$1,056
Boehringer Ingelheim Pharmaceuticals, Inc.
$926
UCB, Inc.
$859
Celgene Corporation
$687
Aurinia Pharma U.S., Inc.
$683
Radius Health, Inc.
$557
E.R. Squibb & Sons, L.L.C.
$519
GENZYME CORPORATION
$394
Fresenius Kabi USA, LLC
$294
ANI Pharmaceuticals, Inc.
$253
Mallinckrodt Enterprises LLC
$191
MEDEXUS PHARMA, INC.
$159
Horizon Pharma plc
$158
DePuy Synthes Sales Inc.
$131
Alexion Pharmaceuticals, Inc.
$127
Janssen Scientific Affairs, LLC
$125
Genentech USA, Inc.
$111
Mallinckrodt LLC
$108
TerSera Therapeutics LLC
$80
MEDAC PHARMA, INC.
$79
Sobi, Inc
$73
Mallinckrodt Hospital Products Inc.
$73
Kyowa Kirin, Inc.
$71
Antares Pharma, Inc.
$61
Forte Bio-Pharma LLC
$60
Ultragenyx Pharmaceutical Inc.
$50
Oxford Immunotec USA Inc
$37
Organon Llc
$33
Octapharma USA, Inc.
$28
Azurity Pharmaceuticals, Inc.
$25
SANOFI-AVENTIS U.S. LLC
$24
FIDIA PHARMA USA INC.
$23
Organon LLC
$21
Flexion Therapeutics, Inc.
$19
Merck Sharp & Dohme Corporation
$17
Celltrion USA Inc.
$13
Cumberland Pharmaceuticals, Inc.
$13
Top 3 companies account for 33.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CRYSVITA · CYLTEZO · Cimzia · EVENITY · Enbrel · HADLIMA · HUMIRA · Horizant · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · Nalocet · NuDyn · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ORENCIA · ORTHOVISC · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · T-SPOT.TB8 · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · XELJANZ · XYOSTED · YUFLYMA · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Orange?
Compare rheumatologists in the Orange area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
115
Per 100K population
3.6
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Khaleghi is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Khaleghi experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Khaleghi performed 435 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khaleghi receive payments from pharmaceutical companies?
Yes. Dr. Khaleghi received a total of $30,464 from 47 companies across 1,468 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khaleghi's costs compare to other rheumatologists in Orange?
Dr. Khaleghi's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khaleghi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →